GovChime
Archived

Antibacterial Nanoparticles Therapeutic (ANT) Study

Overview

Response deadline
2:00 PM EDT
Posted
April 14, 2026
Notice type
Special Notice
Set-aside
No Set aside used
Agency
Department of WarDEFENSE HEALTH AGENCY (DHA)

Notice details

Office
ARMY MED RES ACQ ACTIVITY
Place of performance
Silver Spring, Maryland, 20910
Last updated
Oct 31, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
PANDHA-26-P-0000_036893
Notice ID
68fa274eefb242f796d5ee5a4d4d3c37

Description

The University of Notre Dame will conduct a study to test innovative antibacterial nanoparticles with phage-mimicking properties (PhANPs) against combat relevant multi-drug resistant (MDR) strains of Pseudomonas (P.) aeruginosa, bacterial pathogen to cause hard to treat and even deadly infections in service members after battlefield injuries. There is a need to bring novel therapeutics to the military health care to treat MDR P. aeruginosa. The collaborative partner of this study is the University of Notre Dame, the patent owner of a unique technology (phage-mimicking nanoparticles) that provides life-saving therapeutics for service members and civilians. This technology was awarded a patent in 2024 - US-12161725-B2. Government anticipates that the collaborative efforts will contribute to Food and Drug Administration (FDA) approval of this innovative therapy, leading to reduced morbidity and mortality rates, enhanced operational readiness, advanced combat medicine, and substantial contributions to broader biosecurity initiatives and civilian health improvements.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (2)

  • B01. Notice of Intent to Sole Source PANDHA-26-P-0000 036893.pdf

    62 KBAdded in Special Notice version 5Posted
    Download
  • A02. Request for Information PANDHA-26-P-0000 036893 ANT Study.pdf

    221 KBAdded in Sources Sought version 4Posted
    Download

Lifecycle

  1. 4
    Version 4Sources SoughtArchived

    Antibacterial Nanoparticles Therapeutic (ANT) Study

    Notice 2dc9538915e14664b602b2539c48d0ed on SAM.gov

  2. 5
    Version 5Special NoticeArchivedCurrent

    Type changed from Sources Sought to Special Notice

    Antibacterial Nanoparticles Therapeutic (ANT) Study

    Notice 68fa274eefb242f796d5ee5a4d4d3c37 on SAM.gov

  3. 9
    Version 9Award NoticeArchived

    Type changed from Special Notice to Award Notice

    Antibacterial Nanoparticles Therapeutic (ANT) Study

    Notice 754a19a558d64976a1f2e93870913a09 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

PANDHA-26-P-0000_036893

Archive Date

May 13, 2026

Office Address

FORT DETRICK, MD, 21702